Henry Schein is now the exclusive U.S. distributor of CytoChip — the only CLIA Waived 5-Part Differential CBC Analyzer on the market.

I'm thrilled to share a major milestone for point-of-care diagnostics. This is a game-changer for labs seeking fast, accurate, and waived CBC testing at the point of care.  Whether you're looking to expand your POC testing menu, simplify workflows, or reduce complexity in your CBC program — CytoChip delivers a truly differentiated solution that no other platform in the U.S. can match.

Why this matters for your lab:

-CLIA Waived
No high-complexity certification required — easier compliance, broader deployment.

-5-Part Cartridge-Based
Full 5-part differential CBC from a single, self-contained cartridge — no reagents, no hassle.

-First & Only in the U.S.
CytoChip is the only CLIA Waived 5-part cartridge CBC analyzer available in the U.S. market today.

-The full press release detailing the Henry Schein / CytoChip exclusive partnership is attached below for your review.
Henry Schein Enters Exclusive Distribution Agreement with CytoChip | Henry Schein Investor Newsroom
-Learn More about the CitoCBC and connect with a Henry Schein Representative to schedule a demo!
Henry Schein